American Diabetes Association (ADA) 2021

Dapagliflozin Increases Adiponectin and Its Receptors, and Reduces Inflammation and Ceramide Synthesis Enzymes in the Obese Prediabetic Dog

Risk of Severe Complications of Urinary Tract Infection in Real-World Use of Dapagliflozin

Risk of Acute Liver Injury in Real-World Use of Dapagliflozin

Risk of Acute Kidney Injury in Real-World Use of Dapagliflozin

SGLT2 inhibition promotes myocardial ketone utilization in the normal and failing heart

The Cardiovascular and Renal Benefits of Dapagliflozin are Independent of Baseline HbA1c – Analyses from DECLARE-TIMI 58

Efficacy and safety of dapagliflozin by baseline glycemic status: a pre-specified analysis from the DAPA-CKD trial

Efficacy and safety of dapagliflozin in type 1 diabetes: the RISING-STAR study

Dapagliflozin and the Incidence of Type 2 Diabetes in Patients with Chronic Kidney Disease

An exploratory phase 2a, randomized, double-blind, placebo-controlled study to evaluate the effect of cotadutide on energy balance in overweight and obese subjects with type 2 diabetes mellitus

Efficacy and safety of cotadutide, a dual GLP-1 and glucagon receptor agonist, in patients with type 2 diabetes mellitus and diabetic kidney disease

Cotadutide (MEDI0382) is Well Tolerated at Doses up to 600 µg with Blood Glucose-Lowering Activity in Japanese Patients with T2DM

Once-Weekly Exenatide in Youth with Type 2 Diabetes: A Pivotal Phase III Randomized Study

Global use of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes: Results from DISCOVER

Inside CKD: projecting the future burden of chronic kidney disease in patients with type 2 diabetes

Inside CKD: Modeling the Direct Economic Burden of Concomitant Chronic Kidney Disease and Type 2 Diabetes: Results from the UK and the US

Inside CKD: Modeling the Clinical Impact of Targeted Urinary Albumin-to-creatinine Ratio Screening in People with Type 2 Diabetes Across the Globe: Results from the UK and the US

Screening in People with Type 2 Diabetes Across the Globe: Results from the UK and the US

Reveal-ckd: Prevalence Of And Patient Characteristics Associated With Undiagnosed Stage 3 Chronic Kidney Disease

Short-term risk of type 2 diabetes mellitus in adults treated with corticosteroids: an observational study